home / stock / myl / myl news


MYL News and Press, Mylan N.V. From 07/25/20

Stock Information

Company Name: Mylan N.V.
Stock Symbol: MYL
Market: NASDAQ
Website: viatris.com

Menu

MYL MYL Quote MYL Short MYL News MYL Articles MYL Message Board
Get MYL Alerts

News, Short Squeeze, Breakout and More Instantly...

MYL - Could Pfizer Be a Millionaire-Maker Stock?

Pfizer (NYSE: PFE) was all over the headlines this week after Monday's promising results regarding the coronavirus vaccines it is co-developing along with BioNTech (NASDAQ: BNTX) . On top of that, the U.S. government said it will pay the companies $1.95 billion to secure as many as 600 ...

MYL - Is Now a Good Time to Buy Pfizer Stock?

Investors were in a frenzy Monday morning after Pfizer (NYSE: PFE) announced early positive results from a potential coronavirus vaccine it is studying in partnership with BioNTech in a phase 1/2 trial held in Germany. Pfizer is collaborating with BioNTech on four potential vaccines in a...

MYL - Mylan to Release Second Quarter 2020 Financial Results on Aug. 6, 2020

HERTFORDSHIRE, England and PITTSBURGH , July 22, 2020 /PRNewswire/ -- Global pharmaceutical company Mylan N.V.  (NASDAQ: MYL) today announced that it will release its second quarter 2020 financial results on Thurs., Aug. 6 , before the open of the U.S. financial markets. The comp...

MYL - Have $2,000? Consider Buying These 2 Top Coronavirus Stocks

Just because we are in a recession doesn't mean it's a bad time to invest in stocks. After all, buying shares of great companies -- and holding these shares for long periods -- remains one of the best ways to accumulate wealth. Of course, before putting your money in the stock market, it's essen...

MYL - 2 Top Cancer Treatment Stocks To Watch In July

The second half of the year could provide some solid wins for investors in the cancer therapeutics market. In recent years, Wall Street has flocked to many of these biotechnology companies because of their potential to deliver cutting-edge treatments and generate long-term returns. As cancer ...

MYL - Viatris Reveals Branding to Reflect New Company's Transformative Strategy

HERTFORDSHIRE, England , PITTSBURGH and NEW YORK , July 9, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Upjohn, a division of Pfizer, today unveiled the logo and branding for VIATRIS ™ , the new company that will be formed by combining Mylan and Upjohn. Experience...

MYL - FDA OKs Mylan Humira biosimilar

Mylan N.V. (NASDAQ: MYL ) and collaboration partner Fujifilm Kyowa Kirin Biologics Co., Ltd. ( OTCPK:FUJIF ) announce the FDA nod for Hulio (adalimumab-fkjp), a biosimilar to AbbVie's (NYSE: ABBV ) top seller Humira. More news on: Mylan, Inc., FUJIFILM Holdings Corporation, AbbVie Inc., ...

MYL - Mylan and Fujifilm Kyowa Kirin Biologics Announce U.S. FDA Approval of Hulio® (adalimumab-fkjp)

HERTFORDSHIRE, England and PITTSBURGH and TOKYO , July 9, 2020 /PRNewswire/ --  Mylan N.V.  (NASDAQ: MYL) and Fujifilm Kyowa Kirin Biologics Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Hulio ® (adalimumab-fkjp), a bio...

MYL - Better Buy: AbbVie vs. Biogen

AbbVie (NYSE: ABBV) and Biogen (NASDAQ: BIIB) are two drugmakers that have moved in opposite directions on the stock market of late. While AbbVie has rebounded nicely from the market crash since late March -- with its stock up by 11.7% year to date as of this writing -- shares of Biogen ...

MYL - Mylan Initiates Voluntary Nationwide Recall of One Lot of Daptomycin for Injection, Due to the Presence of Particulate

HERTFORDSHIRE, England and PITTSBURGH , July 7, 2020 /PRNewswire/ -- Mylan N.V.  (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the consumer level of one lot of Daptomycin for Injection, 500 mg/vial...

Previous 10 Next 10